Jharkhand to Recruit Over 1,200 Doctors to Strengthen Healthcare Services

Merck announces that British Columbia, Nova Scotia, Quebec, and Veterans Affairs Canada have added WINREVAIR (sotatercept) to their public drug formularies, improving access for Canadians with pulmonary arterial hypertension. This marks an important step in expanding treatment options for this rare, progressive, and life-limiting disease. Merck remains committed to working with remaining jurisdictions to ensure timely access for all eligible patients.